ArticleMedicine2025
The relationship between autoimmune diseases and temporomandibular disorders: A study combined with the GEO database.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The aim of this study was to investigate the causal relationship between various autoimmune diseases (AIDs) and temporomandibular joint disorders (TMD) using Mendelian randomized (MR) analysis. Using publicly accessible statistics from genome-wide association studies (GWAS) statistics, we conducted a 2-sample MR analysis to examine the relationship between 5 prevalent AIDs and TMD, including rheumatoid arthritis (RA), multiple sclerosis (MS), ankylosing spondylitis (AS), and systemic lupus erythematosus (SLE) and psoriasis. The inverse variance weighted (IVW) was chosen as the main analysis method. The impacts of heterogeneity and pleiotropy were evaluated to validate the results. Finally, we verify the results using the bioinformatics method. Our MR analysis found RA (inverse variance weighted odds ratio (OR) = 1.087, 95% confidence interval (CI) = 1.027-1.151, P = .004) and MS (OR = 1.081; 95% CI: 1.029-1.135, P = .002) and AS (OR = 1.355; 95% CI: 1.037-1.772, P = .026) may increase the risk of TMD. Additionally, a reverse causal connection was found between TMD and RA (OR = 1.099; 95% CI: 1.006-1.200, P = .027). In addition, bioinformatics analysis revealed common DEGs between RA and TMD, highlighting shared molecular mechanisms that may underlie their association. The results of this study offer compelling evidence that some AIDs, including RA, MS, and AS, increase the likelihood of developing TMD. These results offer fresh perspectives on the fundamental etiological mechanisms of TMD and function as a guide for future clinical interventions aimed at AIDs patients, including early screening and TMD prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.